180 related articles for article (PubMed ID: 35884495)
1. The Genomic Landscape in Philadelphia-Negative Myeloproliferative Neoplasm Patients with Second Cancers.
Hsu CC; Wang YH; Chen YY; Chen YJ; Lu CH; Wu YY; Yang YR; Tsou HY; Li CP; Huang CE; Chen CC
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884495
[TBL] [Abstract][Full Text] [Related]
2. Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.
Liisborg C
Acta Ophthalmol; 2022 Oct; 100 Suppl 271(Suppl 271):3-35. PubMed ID: 36200281
[TBL] [Abstract][Full Text] [Related]
3. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
[TBL] [Abstract][Full Text] [Related]
4. Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.
Palomo L; Meggendorfer M; Hutter S; Twardziok S; Ademà V; Fuhrmann I; Fuster-Tormo F; Xicoy B; Zamora L; Acha P; Kerr CM; Kern W; Maciejewski JP; Solé F; Haferlach C; Haferlach T
Blood; 2020 Oct; 136(16):1851-1862. PubMed ID: 32573691
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing.
Maddali M; Venkatraman A; Kulkarni UP; Mani S; Raj S; Sigamani E; Korula A; A FN; Lionel SA; Selvarajan S; Manipadam MT; Abraham A; George B; Mathews V; Balasubramanian P
Ann Hematol; 2022 Sep; 101(9):1987-2000. PubMed ID: 35840818
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of JAK2、CALR and MPL gene mutations in 1 648 Philadelphia chromosome negative myeloproliferative neoplasms patients from a single center].
Li MY; Chao HY; Sun AN; Qiu HY; Jin ZM; Tang XW; Han Y; Fu CC; Chen SN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):295-300. PubMed ID: 28468090
[No Abstract] [Full Text] [Related]
7. Overview of Transgenic Mouse Models of Myeloproliferative Neoplasms (MPNs).
Dunbar A; Nazir A; Levine R
Curr Protoc Pharmacol; 2017 Jun; 77():14.40.1-14.40.19. PubMed ID: 28640953
[TBL] [Abstract][Full Text] [Related]
8. Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms.
Allain-Maillet S; Bosseboeuf A; Mennesson N; Bostoën M; Dufeu L; Choi EH; Cleyrat C; Mansier O; Lippert E; Le Bris Y; Gombert JM; Girodon F; Pettazzoni M; Bigot-Corbel E; Hermouet S
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32872203
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms.
Yonal-Hindilerden I; Daglar-Aday A; Akadam-Teker B; Yilmaz C; Nalcaci M; Yavuz AS; Sargin D
J Blood Med; 2015; 6():157-75. PubMed ID: 26082670
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic factors are increased in circulating granulocytes and CD34
Subotički T; Mitrović Ajtić O; Beleslin-Čokić BB; Nienhold R; Diklić M; Djikić D; Leković D; Bulat T; Marković D; Gotić M; Noguchi CT; Schechter AN; Skoda RC; Čokić VP
Mol Carcinog; 2017 Feb; 56(2):567-579. PubMed ID: 27341002
[TBL] [Abstract][Full Text] [Related]
11. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms.
Vainchenker W; Kralovics R
Blood; 2017 Feb; 129(6):667-679. PubMed ID: 28028029
[TBL] [Abstract][Full Text] [Related]
12. Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53.
Marcellino BK; Hoffman R; Tripodi J; Lu M; Kosiorek H; Mascarenhas J; Rampal RK; Dueck A; Najfeld V
Blood Adv; 2018 Dec; 2(24):3581-3589. PubMed ID: 30563882
[TBL] [Abstract][Full Text] [Related]
13. Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies.
Brune MM; Rau A; Overkamp M; Flaadt T; Bonzheim I; Schürch CM; Federmann B; Dirnhofer S; Fend F; Tzankov A
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830756
[TBL] [Abstract][Full Text] [Related]
14. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
15. Fecal Microbial Community Composition in Myeloproliferative Neoplasm Patients Is Associated with an Inflammatory State.
Oliver A; El Alaoui K; Haunschild C; Avelar-Barragan J; Mendez Luque LF; Whiteson K; Fleischman AG
Microbiol Spectr; 2022 Jun; 10(3):e0003222. PubMed ID: 35475626
[TBL] [Abstract][Full Text] [Related]
16. Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN.
Schnöder TM; Eberhardt J; Koehler M; Bierhoff HB; Weinert S; Pandey AD; Nimmagadda SC; Wolleschak D; Jöhrens K; Fischer T; Heidel FH
J Cancer Res Clin Oncol; 2017 May; 143(5):807-820. PubMed ID: 28233092
[TBL] [Abstract][Full Text] [Related]
17. Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.
Rampal R; Al-Shahrour F; Abdel-Wahab O; Patel JP; Brunel JP; Mermel CH; Bass AJ; Pretz J; Ahn J; Hricik T; Kilpivaara O; Wadleigh M; Busque L; Gilliland DG; Golub TR; Ebert BL; Levine RL
Blood; 2014 May; 123(22):e123-33. PubMed ID: 24740812
[TBL] [Abstract][Full Text] [Related]
18. [Effect of mutation on diagnosis, risk stratification, and treatment decisions in Philadelphia-negative myeloproliferative neoplasms].
Kirito K
Rinsho Ketsueki; 2017; 58(10):1931-1940. PubMed ID: 28978835
[TBL] [Abstract][Full Text] [Related]
19. The roles of sex and genetics in the MPN.
Moliterno AR; Braunstein EM
Int Rev Cell Mol Biol; 2022; 366():1-24. PubMed ID: 35153002
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.
Yonal I; Pinarbası B; Hindilerden F; Hancer VS; Nalcaci M; Kaymakoglu S; Diz-Kucukkaya R
J Thromb Thrombolysis; 2012 Oct; 34(3):388-96. PubMed ID: 22569900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]